Navigation Links
revise in Medical News

Experts Revise Guidelines on Daily Aspirin for Heart

Lower dose appears safe and effective against heart attack in men, stroke in women MONDAY, March 16 (HealthDay News) -- Amid the continuing debate over who should pop an aspirin each day to fight heart disease, and at what dose, U.S. experts have revised guidelines stating that lower d...

WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air

FT. LAUDERDALE, Fla., Aug. 26 /PRNewswire-FirstCall/ -- WaterPure International, Inc. (the "Company" or "WaterPure") (OTC Bulletin Board: WPUR) announced today that it has executed an amended Atmospheric Water Generator (AWG) patent license agreement with Everest Water, Ltd. revising the payme...

Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab

HORSHAM, Pa. and KENILWORTH, N.J., Dec. 21 /PRNewswire-FirstCall/ -- Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP ) today announced they have revised their 1998 distribution agreement regarding the development, commercialization and distribution of both REMICADE(R) (infliximab), ...

NUCRYST and Smith & Nephew Revise Agreements

WAKEFIELD, MA, Oct. 1 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. today announced that on September 30, 2007 it signed amended agreements with Smith & Nephew wound management for the manufacture and sale of Acticoat(TM) dressings with SILCRYST(TM) nanocrystalline coatings. The two c...

VA Should Revise Its Methods for Evaluating PTSD in Ex-military Personnel

To ensure more consistent and appropriate disability compensation for veterans, the U.S. Department of Veterans Affairs (VA) needs to revise how it evaluates former military personnel for service-connected post-traumatic stress disorder (PTSD) and determines the payment amounts they merit, says a ...

FDA to Revise Herpes Test Rules in the US

The Food and Drug Administration (FDA) of the United States proposes to revise rules that could make herpes virus tests cheaper and more extensively available.// The FDA said it might change the classification of tests for herpes simplex virus types 1 and 2 to class II from class III, which woul...

FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics

The Food and Drug Administration FDA has recently announced that it has plans of// reviewing direct-to-consumer prescription drug advertisements. The FDA and the pharmaceutical industry are facing pressure to alter advertising practices for drugs, with agency research showing that many physici...

Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures

...s of the date they are made. Except to the extent otherwise required by federal securities laws, the Company does not undertake to publicly update or revise any forward-looking statements. CONTACT: Caren Villarreal 212-850-5600 caren.villarreal@fd.com ...

Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015

...peak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements. CONTACT: Caren Villarreal 212-850-5600 caren.villarreal@fd.com ...

Nuvo Announces 2009 second quarter financial results

... well as in the Company's Annual Information Form for the year ended December 31, 2008. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether a result of new information or future events, except as required by law. For additional information on risks an...

More>>

revise in Medical Technology

Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filings in Europe

OSAKA, Japan, June 3 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") announced today that it has reviewed the development strategy for the Marketing Authorization Applications (MAAs) for its investigational compounds, alogliptin and alogliptin/ACTOS (generic name: pioglitazone H...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

...orm 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements. Contacts Global Media Relations US Media Relations Pascal Barollie...

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

...the Company concerning trends in the clinical research market and the health care industry. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise. ...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

... filings with the United States Securities and Exchange Commission and BioMS' filings with SEDAR. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. (i) Wucherpfennig KW, Weiner HL, Hafl...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

...ur filing with the Securities and Exchange Commission. The foregoing list is not exhaustive, and the Company disclaims any obligations to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements. Readers should also carefully review the risk fac...

Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA

...n Form 10-K for the year ended December 31, 2008, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise. ...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

...ertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...e undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or revise the information contained in this announcement whether as a result of new information, future events or circumstances or otherwise. GlaxoSm...

Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders

...there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are expre...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

...ress release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release . ...
revise in Medical Dictionary

Rehabilitation

...ation ... The MetroHealth Rehabilitation Institute of Ohio, founded in 1953 as ... To replace the Vocational REHABILITATION ACT, to extend and revise the ... (2) evaluate the REHABILITATION potential of handicapped individuals; ... This is a research guide on rehabilitation provided by the W...
revise in Biological News

New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds

COX-1 and COX-2 enzymes may be blocked by pain medications such as Advil and Vioxx in a more complex manner than was previously understood, a Queen's University study has found. "The results of the study have potential implications for how we classify the commonly used anti-inflammatory and pain ...

Journal of Vascular and Interventional Radiology: New patient radiation safety guidelines

...ality and influence as an academic and professional resource. "Members of SIR's Standards Division have continued to develop new content as well as to revise older documents as appropriate," added the interventional radiologist at Northwestern Memorial Hospital in Chicago, Ill. The 376-page collection g...

Toward cheap underwater sensor nets

...erwater transducer is much more complex than we originally thought" says Kimball. "In class, you learn a lot of theory, but you don't learn how to revise a schematic, layout the printed circuit board, assemble the circuit and then perform field tests. I have friends at other schools, and when it comes t...

Aware, Inc. Announces Final Results of Dutch Auction Tender Offer

...ed in this press release speak only as of the date of the release. Please note that except as required by applicable law we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Aware, Dr. DSL and StratiPHY are trademarks or registered trademarks of Aware,...

Aware, Inc. Amends and Extends Dutch Auction Tender Offer

...d in this press release speak only as of the date of the release. Please note that except as required by applicable law we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Aware, Dr. DSL and StratiPHY are trademarks or registered trademarks of Aware,...

Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer

...ed in this press release speak only as of the date of the release. Please note that except as required by applicable law we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Aware, Dr. DSL and StratiPHY are trademarks or registered trademarks of Aware,...

Aware, Inc. Amends and Extends Dutch Auction Tender Offer

...d in this press release speak only as of the date of the release. Please note that except as required by applicable law we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Aware, Dr. DSL and StratiPHY are trademarks or registered trademarks of Aware,...

UniPixel Announces Availability of Opcuity(TM) Finger Print Resistant Film Test Samples

...any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise any forward-looking statements. Readers are also urged to carefully review and consider the other various disclosures in the Company's Annual Report ...

Aware, Inc. Commences Dutch Auction Tender Offer

...d in this press release speak only as of the date of the release. Please note that except as required by applicable law we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Aware, Dr. DSL and StratiPHY are trademarks or registered trademarks of Aware,...

Aware, Inc. Commences Dutch Auction Tender Offer

...d in this press release speak only as of the date of the release. Please note that except as required by applicable law we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Aware, Dr. DSL and StratiPHY are trademarks or registered trademarks of Aware,...
revise in Biological Technology

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

...lts or developments may differ materially from those set forth in the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances. SCOLR Pharma, Inc. ...

Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

... under "Risk Factors" in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason. ...

AOBO Announces New Product Launch

...r materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. ...

American Oriental Bioengineering Reports Second Quarter 2009 Financial Results

...r materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. AMERICAN ORIENTAL BIOENGINEERING, IN...

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

...filed with the Securities and Exchange Commission in the section entitled "Risk Factors." We have no plans, and disclaim any obligation, to update or revise any forward-looking statements whether as a result of new information, future events or other factors, except as required by law. Website: ...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

...ress release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release. SEQUENOM, ...

PDI Reports 2009 Second Quarter Financial Results

.... In addition, these statements speak only as of the date of this press release and, except as may be required by law, PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason. (Tables to follow) PDI, INC. CONDENSED CONSOLIDATED STATE...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...f the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Amicus undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

...f the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Sectio...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...rm 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements. Contact: Noelle Boyd Richard M. Scarfo Sanofi-aventis Foundation for the...
Other Tags
(Date:2/27/2015)... 27, 2015 With cases of head ... concerned parents look to school administrations to help prevent the ... head lice is a common parasite that passes easily among ... causing parents and teachers significant distress. , The answer ... at the school. This would allow parents and teachers to ...
(Date:2/27/2015)... Las Vegas, NV (PRWEB) February 27, 2015 ... community by collaborating with the online fitness social platform ... discover the quality products and holistic philosophy behind BaliniSports. ... the brand in an intimate way and discover apparel ... yoga apparel brand that uses environmentally friendly and socially ...
(Date:2/27/2015)... 27, 2015 The perennial debate between ... treatment argue that those who are for the use ... of narcotics and alcohol are enabling addicts to continue ... and suboxone, which are synthetic opiate based medications designed ... drug addicts from overdosing. These synthetic opiates satisfy the ...
(Date:2/27/2015)... 27, 2015 Local lice removal service reports ... in the areas of Pinecrest, Key Biscayne, Coral Gables, Miami ... as they attempt to isolate and eradicate the problem. ... “selfie” photograph may be partly to blame. As kids put ... of head-to-head contact that can allow for the spread of ...
(Date:2/27/2015)... 27, 2015 The Radiology Business ... its next class of Fellows — one of the ... business management. , Since 2009, the RBMA Fellowship ... by RBMA members to the Association and the profession. ... because each Fellow candidate must meet a very high ...
Breaking Medicine News(10 mins):Health News:South Florida Parents Put Pressure on Schools to Perform Lice Screenings to Prevent Spread of Lice According to One Miami Lice Removal Company Called Lice Troopers 2Health News:BaliniSports Announces Collaboration with FITMOO 2Health News:America’s Stigma Around Methadone Puts Drug Addicts at an Increased Risk for Fatal Overdose 2Health News:America’s Stigma Around Methadone Puts Drug Addicts at an Increased Risk for Fatal Overdose 3Health News:Parents frustrated as selfies continue to contribute to the spread of head lice in Miami according to the largest Lice Removal Service in Miami called Lice Troopers 2Health News:RBMA Issues Call for Fellowship Applicants 2
(Date:2/24/2015)... 2015 This report analyzes the worldwide markets for ... analytics for the US, Canada , ... Asia-Pacific , Middle East , ... forecasts are provided for the period 2013 through 2020. Also, ... data and analytics are derived from primary and secondary research. ...
(Date:2/18/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that its ... investors to participate via webcast. , Cowen and Company ... March 3, 2015 at 11.20 a.m. Eastern Time , ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... for these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25
Other Contents